2019
- Community Letter from Wave Life Sciences Regarding Topline Results from PRECISION-HD2
- Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease
- HDSA Earns Fourth Consecutive 4-Star Rating From Charity Navigator
- HDSA Awards Inaugural Clinical Research Pilot Grants to Four Centers of Excellence
- HDSA Listed As Top 10 Volunteer Opportunities In New York City By Great Nonprofits
- HDSA Welcomes Three Trustees to National Board
- HDSA Publishes The Marker – 2019 Research Report
- HDSA’s New York City Marathon Team Raises More Than $133,000 To Support The Fight Against HD
- HDSA Awards Five 2019 HD Human Biology Project Fellowships
- Community Statement from Roche / Genentech
- View 5th Annual Freeze HD Red Carpet and Event Photos
- 5th Annual Freeze HD Raises More Than $420,000 To Support HDSA
- 2018 HDSA Annual Report
- HDBUZZ: Exciting New Huntingtin Lowering Tool Described
- Now Accepting 2020 HDSA Centers of Excellence Letters of Interest
- VIDEO: Here’s The Deal With Caregiving While Positive
- VIDEO: 34th Annual HDSA Convention Recap
- HDSA Sets New Attendance Record at the 34th Annual HDSA Convention in Boston
- Community Statement from uniQure
- HDSA & CHDI Foundation Launch HD Legacy to Promote Brain Donation for HD Research
- HDSA Adds Allison Bartlett as Manager of Disability Programs
- HDSA Awards 2019 Berman-Topper Family HD Career Development Fellowships
- Huntington’s Disease Parity Act Is Reintroduced
- HDBUZZ: Fresh Updates from First Huntingtin Lowering Study Publication
- Postcard from Palm Springs: Highlights from the 2019 CHDI HD Therapeutics Conference
- HDSA Announces Winners of 2019 Donald A. King Summer Research Fellowship
- HDSA Films Presents “The Hodgsons” Short Film
- Update on PRECISION-HD program
- BLOG: This Week in HD Research
- HDBUZZ: An Updated Trial Design for Roche’s Huntingtin Lowering Trial: Roche announces an update to the GENERATION HD1 trial after reviewing the ASO open label extension study
- COMMUNITY STATEMENT FROM ROCHE/GENENTECH: Amendment to the RG6042 Phase III GENERATION HD1 study design
- HDBUZZ: Genetic Hiccups That Protect Against Huntington’s Disease
- HDBUZZ: Huntington’s Disease Therapeutics Conference 2019 – Day 3 Recap
- HDBUZZ: Huntington’s Disease Therapeutics Conference 2019 – Day 2 Recap
- Huntington’s Disease Featured On The Today Show
- HDSA Expands Centers of Excellence Program to Forty-Seven
- HDBuzz: Huntington’s Disease Goes Viral as uniQure Inches Ahead in Gene Therapy Race
- First Patients Enrolled in HD Natural History & GENERATION HD1 Clinical Studies
- HDSA Publishes 2018 Year In Review Magazine
- uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease
- HDSA Launches Youth Social Worker Program
